| 37.82 Data as of May 24 |  -0.12 / -0.32%Today’s Change | 3.30 Today|||52-Week Range 45.00 | +46.59% Year-to-Date |
| Previous close | 37.94 |
| Today’s open | 38.19 |
| Day’s range | 37.50 - 38.85 |
| Volume | 973,862 |
| Average volume (3 months) | 1,975,696 |
| Market cap | $1.2B |
| Dividend yield | -- |
| Earnings growth (last year) | -4,183.33% |
| Earnings growth (this year) | +31.20% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | -20.56% |
| P/E ratio | NM |
| Price/Sales | 16.31 |
| Price/Book | 9.69 |
| Today’s change | Today’s % change | |
|---|---|---|
| INFIInfinity Pharmaceuti... | -0.06 | -0.25% |
| PDLIPDL BioPharma Inc | +0.02 | +0.24% |
| ACADACADIA Pharmaceutica... | +0.40 | +2.89% |
| IPXLImpax Laboratories I... | +0.20 | +1.08% |
| Next reporting date | August 12, 2013 |
| EPS forecast (this quarter) | -$0.63 |
| Annual revenue (last year) | $37.3M |
| Annual profit (last year) | -$121.3M |
| Net profit margin | -324.91% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Christopher Nishan Garabedian |
Chief Financial Officer & Senior Vice President Sandesh Mahatme |
Corporate headquarters Bothell, Washington |
.
